Cargando…
Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial
BACKGROUND: Alpha lipoic acid (ALA) is considered a strong antioxidant with anti-inflammatory properties. Moreover, a number of previous studies have shown its lipid-lowering properties. Therefore, we designed this study to investigate the effects of ALA on lipid profile in patients with metabolic s...
Autores principales: | Ahmadi, Mahbubeh, Keshavarz, Seyed Ali, Abbasi, Behnood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937669/ https://www.ncbi.nlm.nih.gov/pubmed/36817351 http://dx.doi.org/10.22122/arya.2022.26181 |
Ejemplares similares
-
Effect of Alpha-Lipoic Acid Supplementation on Low-Grade Squamous Intraepithelial Lesions—Double-Blind, Randomized, Placebo-Controlled Trial
por: Divković, Anja, et al.
Publicado: (2022) -
The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
por: Abbasi, Behnood, et al.
Publicado: (2012) -
Does Alpha-lipoic Acid Supplement Regulate Blood Pressure? A Systematic Review of Randomized, Double-blind Placebo-controlled Clinical Trials
por: Mohammadi, Vida, et al.
Publicado: (2017) -
Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study
por: Kolahi, Sousan, et al.
Publicado: (2015) -
Effect of Alpha Lipoic Acid Supplementation on Oxidative Stress and Lipid Parameters in Women Diagnosed with Low-Grade Squamous Intraepithelial Lesions (LSILs): A Double-Blind, Randomized, Placebo-Controlled Trial
por: Divković, Anja, et al.
Publicado: (2023)